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Abstract
Health-related stigma causes a negative impact on the lives of affected people and undermines the effectiveness of public health programs. This study aimed
to explore experiences and consequences of stigma among people affected by four health conditions relevant in Indonesia– HIV (Human Immunodeficiency
Virus), leprosy, schizophrenia and diabetes. In this qualitative study 40 people affected by the four health conditions in Jakarta and West Java, Indonesia–,
were interviewed between March and June 2018. Data were analyzed thematically by following an integrative inductive-deductive approach. The experiences
and consequences of people with stigma were similar, but such experience were more severe among people affected by HIV, leprosy, and schizophrenia.
Those with diabetes either experienced no or less severe stigma. The participants revealed that they experienced enacted stigma in healthcare, employment,
and social interactions in the structural and interpersonal levels. They also experience the stigma in the form of internalized and anticipated stigma at an in-
dividual level. Incidences of human rights violations were evident. Social, behavioral, psychological, and medical consequences were also reported. 
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Introduction
Health-related stigma is a global health issue that
 undermines the effectiveness of public health programs
and negatively impact on the lives of affected  people.1 It
affects people living with infectious diseases, such as
HIV (Human Immunodeficiency Virus),2 and leprosy,3,4
and mental health  conditions, such as schizophrenia.5 It
also affects people with  noncommunicable diseases, in-
cluding diabetes,6,7 and cancers.8,9 As a social phenom-
enon, stigma occurs  within the society and usually de-
pends on the nature of a disease.10 People with commu-
nicable diseases, such as HIV or leprosy, experience stig-
ma because of the  infectious nature of diseases.11,12
They are often blamed for having a transmissible disease
and are avoided by others, especially when consequences
of the condition are visible, as in leprosy.4,11,13 People
living with  noncommunicable diseases, such as diabetes,
are known to be blamed and shamed for their lifestyles
and for  inflicting the condition on themselves.6,7 People
living with chronic mental health conditions, such as
 schizophrenia are perceived to be aggressive and
 dangerous, so they are socially avoided and rejected.5,14
People with different health conditions experience
stigma that negatively affects their social, physical,
 psychological, and spiritual well-being.2,12,15 It reduces
the degree of access and uptake of health care services,
causing the underdiagnosis of conditions, failing to
 detect mental health issues, and delaying and disrupting
treatment.16-18 Such consequences of stigma affect
 preventive and treatment measures for eliminating these
diseases, ultimately hampering advancements in
 decreasing the burden of diseases.19,20
Low-and middle-income countries (LMICs) are
known to be disproportionately affected by health-
 related stigma because of the existence of subjugating
social norms, lack of health awareness, and inequitable
access to health services that contribute to stigma and
its negative effects.21,22 However, much of the burden
of health-related stigma in LMICs still remains hidden
and unaddressed because of the lack of wider
 recognition in health policies and practices.21
As the world’s fourth-most populous developing
 nation currently in epidemiological transition with
 relatively high prevalence and distribution of
 noncommunicable and communicable diseases,
Indonesia is particularly vulnerable to the burden of
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 stigma compared with other Southeast Asian
 countries.23,24 It has the highest prevalence of HIV in
the Southeast Asian region,25 and leprosy has the third-
highest prevalence in the world.26 The prevalence of
noncommunicable diseases, such as diabetes mellitus
(6.7% in adults) and schizophrenia (around 1%), is
high.27,28 With a high burden and growing prevalence
of these four diseases in the Indonesian society, these
diseases have a social effect, that is, stigma and its
 experiences in the daily life of affected people.20 In this
regard, the stigma related to these four different
 diseases, which are relevant to the health of the
Indonesian population, should be further explored and
understood. 
Few studies have reported the negative experiences
of stigma among people with HIV,29-34 and leprosy.3,4,
11,35-37 in Indonesia. Subu, et al.,38 reported the stigma
associated with mental illnesses, including schizophrenia
in Indonesia. The Human Rights Watch,39 published a
report on the rampant human rights violations among
people with schizophrenia and other mental illnesses in
Indonesia. Two studies,40,41 have reported the commu-
nity perceptions of people with diabetes and the general
experiences of persons living with diabetes in Indonesia.
However, studies have focused on the stigma
 experiences of people with schizophrenia and diabetes.
Furhtermore, the experiences of the stigma across
 different health conditions with different kinds of
 nature, etiology, and attribution, should be compared
with record the differences and similarities among those
experiences, particularly in the context of the Indonesian
culture. Such insights not only help further understand
the processes and experiences of stigma across different
health conditions and within the specific Indonesian
 cultural context, but also have strong implications for
public health programs in effectively responding to
 stigma in a variety of health conditions. Therefore, this
study aimed to explore aimed to not only explore but
 also compare the experiences and consequences of
 stigma among people with HIV, leprosy, schizophrenia,
and diabetes. The comparison was done among the four
disease groups in order to see if there were any differ-
ences, however, the experiences and consequences were
very similar across the groups.
Method
This study was a part of an exploratory community-
based study on health-related stigma conducted in
Jakarta and West Java in Indonesia between March and
June 2018 among people living with/affected by four
 stigmatized health conditions, namely, HIV, leprosy,
schizophrenia, and diabetes. The study locations were
 selected on the basis of the higher proportion of
 individuals with different health conditions in these
 regions. The participants with HIV and diabetes were
 recruited in Jakarta, those with leprosy were recruited in
Cirebon, West Java, and those with schizophrenia were
recruited in Jakarta and Cianjur, West Java. Purposive
convenience sampling was used to recruit participants
from the community through referrals and recruitment
by community-based organizations and peer-support
groups related to the four different conditions. Those
who were over the age of 16 years (age of consent) and
who were willing and consented to participate were
 included in the study. Therefore, 40 participants (10
from each of the four health conditions) were recruited
and interviewed. 
Scambler’s hidden distress model of stigma,42 was
used as a theoretical framework to develop the interview
guide and analyze data. The framework categorized the
experiences of stigma into two types: enacted (actual
 experiences of stigmatizing acts, attitudes, and behavior
from others) and felt stigma (acceptance of stigmatizing
social views and resultant feelings of shame [internalized
stigma] and fear of being vilified because of the
 stigmatizing trait [anticipated  stigma]).43 These
 categories of stigma experiences are  embedded within
the  socio-ecological levels where stigma exists at
 structural, interpersonal, and individual levels of the
 society.5 Enacted stigma occurs at structural and
 interpersonal levels,14,44 and felt stigma is experienced
at the individual level.14,45
The interview guide was developed on the basis of the
 theoretical framework on Scambler’s hidden distress
model of stigma,42 and multiple consultations with
 research experts (three from Athena institute, Vrije
University Amsterdam, the Netherlands and two from
the Faculty of Psychology, Atma Jaya Catholic University,
Indonesia), and representatives from nongovernmental
organizations and the different disease groups. Pilot
 interviews were first conducted with four participants
(one from each health condition) to test the  applicability
and appropriateness of the interview guide and the
 interview technique. The interview guide included open
questions on the experience of living with a stigmatized
health condition, the experiences of stigma as a result of
the health condition, and the resultant  consequences of
stigma. The interview guide was subsequently refined
and adjusted by further outlining the questions on the
experiences of stigma into structural (stigmatizing
 policies and systems in the society), interpersonal (stigma
in family and social circles), and intrapersonal (self-
 perception of stigma) levels. The respondents were
 approached and asked to participate in the study. Those
who agreed were either interviewed at their homes or in
nongovernmental organization offices privately. The
 interviews started in an exploratory manner asking about
the general daily experience of living with their health
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condition, progressed toward more in-depth questions
on specific examples of their personal experiences with
stigma and its consequences, and lasted an average of
one hour. In-depth probing was conducted until response
saturation. Data were collected by a team of one
Indonesian research associate from Vrije University
Amsterdam and two research assistants from Atma Jaya
Catholic University in Indonesia language under the
 supervision of the main researcher. The research team
were trained on interview techniques and strategies for
qualitative data collection prior to fieldwork (in the first
week of March). Data were recorded electronically,
 transcribed verbatim, translated, managed, and analyzed
with the qualitative software package Atlas.ti. 
Data were analyzed through thematic content
 analysis,46 and data were iteratively coded and
 thematically categorized using an integrative inductive-
deductive approach,47 to derive the inference. The
 transcripts were coded and thematically categorized into
two, namely, experiences and consequences of stigma.
The experiences of stigma were deductively categorized
on the basis of the underpinning theory of Scambler’s
hidden distress model of stigma.42 The codes were first
categorized into three different socioecological levels,
e.g., structural, interpersonal, and intrapersonal, levels,
by using the deductive approach and then sub categorized
into enacted stigma under the structural and
 interpersonal levels and felt stigma (internalized and
 anticipated) under the intrapersonal level. The
 consequences of stigma were inductively derived and
 categorized on the basis of the emerging themes: social,
behavioral, psychological, and medical consequences.
The analytical process was peer debriefed and discussed
at each stage to ensure the quality and validity of codes,
categories, and themes. 
The study was approved by the Ethics Committee of
Atma Jaya University (Approval ID: FR-UAJ-26-13/R0).
Written consent was obtained from individual study
 participants. Refreshments were given to the participants
and their transportation costs were refunded as a token
of appreciation for their participation.
Results
A total of 40 participants, with ten each with HIV,
leprosy, schizophrenia, and diabetes, were interviewed.
Of these participants, 21 were females (52.5%), 18 were
males (45.0%), and 1 was a transgender (2.5%). The
median age of the participants was 40.9 years (Standard
Deviation 11.54) with an age range of 19 - 75 years. The
mean duration of living with/having had the condition
was 10.4 years (SD 5.8) with a range of 1 - 25 years. In
terms of ethnicity, the majority (40%) of the participants
were Javanese,  followed by Sundanese (20%), Chinese
(15%), and  others (25%). Most of the participants were
Muslims (62.5%), and the remaining participants were
Christians (32.5%) and Buddhists (5.0%). The majority
of the  participants reached the senior high school level
or higher (82.5%), and were employed (76.3%).
The key themes of the experiences of stigma and its
consequences are presented in Figure 1. The experiences
were deductively categorized into three different levels
as per the socioecological level framework, e.g.,
 structural, interpersonal, and intrapersonal levels.
Participants experienced two distinct types of stigma,
namely, the enacted stigma that manifested at structural
and interpersonal levels, and felt stigma which
 manifested in the individual level. The experiences of
stigma were reported at multiple levels of the society by
all the participants affected by HIV, leprosy, and
 schizophrenia. Only six participants with  diabetes
 reported that they experienced stigma, whereas four
 participants did not perceive any stigma because of their
Figure 1. Key Themes of Experiences of Stigma and Its Consequences
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condition.
The participants reported of experiencing enacted
stigma because of existing policies and practices, and
 social and cultural norms at the structural level. People
living with HIV and schizophrenia reported exclusionary
policies and practices in health institutions. For example,
participants with HIV reported that they were denied of
treatment or refused to receive treatment after they knew
their HIV status, were allowed in-house hospital
 admissions only in private rooms, and used overt
 practices to avoid contamination. Some participants with
HIV and schizophrenia also reported severe human
rights violations because of hospital policies. For
 example, one woman living with HIV recounted her
 experience of the hospital administration handing her a
consent form for sterilization to sign right before the
 delivery of her child, 
“I was in a position where I could not refuse. I was only 22
years old then (in 2008). At first, I did not want to do it, but
the doctor said if I did not want to (sign the consent form), he
would not operate. I had my first child at 22 years old and got
sterilized.” (Female, HIV, AH010) 
Three people with schizophrenia talked about their
experience of involuntary captivity and isolation
 practiced in a hospital as a way to subdue patients. 
The participants reported that they experienced
 exclusionary policies in the job market. Three
 participants with diabetes indicated that they
 experienced discrimination in jobs that involved physical
labor or heavy workload, which they were either not
hired or excluded from participating because of their
 disease. People affected by leprosy with visible spotting
or deformity stated problems in having a job in public
and private sectors. Those who have HIV and
 schizophrenia and discolse their health status reported
that they were rejected or dismissed from jobs. Most
 participants affected by HIV, leprosy, and schizophrenia
stated their preference to either work in non-
 governmental organizations (NGOs) related to their
 respective health condition or open their own business
to avoid stigma. Several people with schizophrenia
 reported that they worked as Go-Jek (online motorbike
ride sharing service in Indonesia) drivers to minimize
 interactions with the employers and colleagues. 
The participants also talked about how poverty
 further impacted their experience of stigma. They
 reported that the lack of finances limited their access to
health care, thereby worsening their condition and its
manifestations. One participant with HIV called it
 “double stigma” of being “sick” and “poor.” However,
some participants also talked about how some
 improvements are happening, such as BPJS (Indonesian
National Health Insurance), which helps them and other
poor people avail inexpensive medical treatment. 
The participants also reported that they had adverse
experiences of stigma because of existing socio-cultural,
religious, and gender norms. People with/affected by
HIV, leprosy, and schizophrenia reported that religious,
superstitious, and mystical beliefs in the society, such as
sin or bad deeds, curses, witchcraft, and influence of evil
spirits, were the cause of their diseases. They also talked
about how socially held stereotypes played a role in
 stigmatizing individuals with diseases. Those with HIV
and leprosy also reported the fear of people about
 contracting the disease from them because of their lack
of knowledge. The participants living with schizophrenia
reported that the society perceived people with
 schizophrenia as “crazy” or “aggressive”, leading to
stigmatization and discriminatory practices against them.
Three participants recounted their experience of being
tied and shackled, which is an act called “pasung” in
Indonesian, to restrain them. On the contrary, people
with diabetes reported that they received support and
 acceptance from the society. They stated how diabetes
was considered “normal” in the Indonesian society
 because many people in the community were more
 familiar with the disease. Four female participants with
HIV and three with diabetes described how women were
judged more harshly than men in the society and
 recounted of being considered irresponsible and vilified
for making “bad decisions.”
The participants described their experiences of stigma
at an interpersonal level from health care professionals,
friends, and family. All the participants except those with
diabetes, reported their negative experiences with
 healthcare professionals. They were either discriminated
against or disrespected because of their disease. The
 participants affected by leprosy reported that health care
staff refrained from touching them; for instance, health
care people would not shake hands with them. The
 participants with schizophrenia commented on feeling
condescended by how healthcare workers treated them
and talked to them—they felt like they were not adults or
in control of their life. Those with HIV talked about how
some health workers did not value and respect the
knowledge, experiences, and views of patients. One
 participant said,
“In this day and age, health care workers still think that they
are the only ones with knowledge (on HIV-related issues) be-
cause they went to  medical school. I rarely find a doctor who
wants to accept inputs from us.” (Female, HIV, AH013)
Most participants talked about experiencing stigma
and discrimination from family and friends. The
 participants reported that they were ridiculed and
 harassed by friends. Three participants affected by
 leprosy reported that they were being shunned because
of visible spotting or deformity and called “ugly.” One
participant living with schizophrenia described how his
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 impending fear of stigma and discrimination in the
 future. People affected by HIV, leprosy, and schizo -
phrenia talked about their fear of people distancing them-
selves from them or being excluded from social  settings
if their health conditions were disclosed. One participant
with diabetes talked about how she was scared of being
pitied or ridiculed for having the disease and people
might start attributing the condition to their weight, eat-
ing habits, or lifestyle choices. 
According to the participants’ responses, the
 consequences of stigma were inductively categorized into
four distinct categories, that were social, behavioral,
 psychological, and medical consequences. Most
 participants talked about social consequences, which
 primarily constituted of strained or severed relationships
with friends and family, damaged reputation and social
standing in the community, and limited work  opportunity
and career progression. Most participants with schizo-
phrenia talked about how their relationships with their
family and friends deteriorated because of their condi-
tion. One participant with schizophrenia  recounted how
his wife left him. Another participant talked about how
his fiancée cancelled their wedding and broke up with
him after knowing his condition. Most participants af-
fected by HIV, leprosy, and schizophrenia talked about
how their social standing and reputation were tarnished
because of their disease status. Many  participants, includ-
ing two with diabetes, reported that their disease condi-
tion limited their prospects of having jobs or hampered
chances of career progression or  promotion in their ex-
isting jobs. 
The participants reported that they encountered
 behavioral consequences that included shutting
 themselves off from their friends, family, and the society
by either concealing their health condition or isolating
themselves from the society. They also reported
 psychological consequences, including stress, anxiety,
 severe depression, and suicidal ideation. People living
with schizophrenia and HIV reported psychological
 consequences the most. Those with schizophrenia
 reported the most instances of suicidal ideation and
 attempts, and those with HIV described stress, anxiety,
and depressive symptoms as a result of stigma.
Participants affected by HIV, leprosy, and schizo -
phrenia talked about two specific medical consequences,
such as avoiding medical care and disrupting treatment.
People living with HIV and schizophrenia talked about
how stigma experienced in the healthcare settings
 deterred them from visiting certain health facilities or had
to trasnfer to another hospital or change their doctors.
Those affected by leprosy and schizophrenia talked about
how stigma disrupted their treatment and adherence to
medication. They described how superstitious beliefs
made them leave their medical treatment and seek
friends saw him take his medicine and told everybody he
was using “drugs (narcotics)”. The participants with
 diabetes reported how friends and family intervened
while they were eating and either stopped them or
shamed them for eating unhealthy. Some participants
 reported that they felt stigmatized because of
 interference, but most of them considered the act as
 caring and considerate and did not feel stigmatized. 
The participants affected by HIV, leprosy, and
 schizophrenia particularly talked about how their family
felt ashamed and embarrassed because of their disease.
They described how their families were fearful of others
knowing about their disease and tried to conceal it from
others. The participants also reported about the
 exclusionary behavior from their family members. One
participant with HIV talked about how people in his
 family separated all kitchen utensils used by him and
 disinfected his bedding and clothes. The participants with
schizophrenia reported that they were excluded from
family discussions or important decision making. One
participant said,
“I was never involved in any important occasion at my home.
For instance, during my nephew’s wedding, I was not involved
to make any  decisions. They did not trust me.” (Male,
Schizophrenia, SS004)
The participants reported that they felt stigma at an
individual level in the form of internalization and
 anticipation of stigma. They described the internalized
stigma in the form of acceptance and self-endorsement of
negative stereotypes, shame, self-blame, and self-
 deprecation. Some participants affected by leprosy and
schizophrenia reported that they agreed with and
 accepted the cultural and religious beliefs that their
 condition was because of their “sin,” “curses,” and “bad
spirits.” The participants also reported that they
 identified with negative stereotypes associated with
health conditions. One man with schizophrenia said,
“I felt really down to know that I was mentally ill and was
worried if I would ever be able to get  better. Everybody knows
that having schizo phrenia equal to being mentally ill.” (Male,
Schizophrenia, SS009)
Most participants affected by HIV, leprosy, and
 schizophrenia were also embarrased for having the
 disease and feeling useless. Some participants living with
HIV and diabetes reported that they blamed themselves
for their condition. Those living with HIV blamed
 themselves for their past behavior that led them to have
HIV. Two participants with diabetes talked about how
they blamed their eating habits and lifestyle for their
 condition. 
The participants also reported that they experienced
anticipation and fear that they might experience negative
stigmatizing attitudes from others. The participants who
disclosed their health conditions expressed their
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 alternative treatment from faith healers, shamans, and
witchdoctors. One participant affected by leprosy talked
about how disrupting his treatment led to his disability, 
“I was taking medicine (for leprosy), but because we (my fam-
ily and I) all thought I was cursed, I stopped my medicine and
consulted a faith healer instead. Now, I have a deformity in my
leg.” (Male, Leprosy, AK004)
Discussion
This study explored the experiences of stigma among
people living with/affected by HIV, leprosy,
 schizophrenia, and diabetes in Indonesia. The
 experiences and consequences of stigma were similar, but
such consequences were more severe among people with
HIV, leprosy, and schizophrenia. Those with diabetes
 either experienced no or less severe stigma. The
 experiences of stigma were evident in all three  socio-
 ecological levels in the Indonesian society. Enacted
 stigma was experienced in health care, employment,
 social interactions, and within families at structural and
interpersonal levels, and felt stigma in the form of
 internalized and anticipated stigma was reported at an
individual level. The incidences of human rights
 violations were evident. The social, behavioral,
 psychological, and medical consequences of stigma were
identified. 
Even though the health conditions were different in
nature and etiology, the experiences and consequences of
stigma were similar. This finding was consistent with the
works of Rao,10 and Van Brakel,48 who emphasized that
the experiences of stigma associated with them were
mostly the same despite the different characteristics,
 attributions, and origins of diseases. Studies on stigma
have also found that the severity and intensity of such
 experiences may differ in terms of disease condition even
though the experiences of stigma are similiar.22,49,50 This
finding was evident from the study findings, which
showed that people with diabetes experienced either no
or less severe form of stigma compared with those with
the three other conditions. Their experiences were mostly
limited to judgments and comments from people around
them. Even then, some of the affected people did not
 perceive such behavior as stigmatizing; instead, they
 believed that this behavior was a supportive and caring
gesture for the good of their own health. This might have
to do with the normalization of diabetes in the Indonesian
society because of its higher prevalence and wider exis-
tence, considering that many families have members liv-
ing with the condition.40,41 Pitaloka and Hseih,40 report-
ed that Javanese women with diabetes perceived their
condition as a normal part of their daily lives and consid-
ered it to be an ordinary illness that was not severe. A
study conducted in Central Java, Indonesia showed that
diabetes is largely hereditary, and other  people em-
pathized with those who had the condition, even though
the public had a negative perception about diabetes as a
terrifying disease without cure and blamed people with
diabetes for their dietary habits and  sedentary lifestyle.41
For people with HIV, leprosy, and schizophrenia, the
experiences of stigma were more severe and damaging.
As the world’s most populous Muslim-majority country,
Indonesia not only has Islamic traditions and practices,
but also has deeply rooted superstitious traditions and
practices embedded in the local culture that can
 exacerbate stigma of these three diseases.4,51,52 Islamic
law prohibits homosexuality, extramarital sex, and the
drug use, which force stigma and human rights violations
toward people living with HIV that belong to the
 vulnerable groups.51,53 Leprosy in Indonesia is often
considered a result of black magic, curse, or sinful deeds
in impoverished communities where superstitious beliefs
are prevalent.4 In case of schizophrenia, medical
 treatment opportunities are limited in rural areas in
Indonesia, and people often resort to age-old practices,
such as pasung (shackling of people with schizophrenia
to subdue them), which violate the human rights of those
affected.39,54 People also attribute schizophrenia to
 possession by evil spirits or God’s punishment, and
 consider pasung as the only way to cure diseases by
 confining a person until he/she becomes free of evil
 spirits.54,55 The stigmatization of these conditions is
 unfortunately driven by cultural traditions and norms,
existing exclusionary policies and practices in healthcare
and employment sectors,11,38,39 and by societal actors -
healthcare workers, friends, family, and neighbors,38,56
which corroborate the findings of this study. Consistent
with the study findings, the experiences of felt stigma
through internalization and anticipation of stigma are
further known to intensify self-stigmatization.3,29,38
Lusli, et al.,3 found that Indonesians with leprosy usually
internalize the shame and endorsement of the negative
stereotype of having this condition. The internalization
of shame was also reported in a study conducted in
Indonesia among people living with schizophrenia and
other mental illnesses.38 Culbert, et al.,29 reported about
the fear of stigma among prisoners with HIV in
Indonesia, and this condition affects their decision to
 disclose their condition to others. 
The consequences of stigma were similar to those
 reported from other studies on stigma globally, including
social consequences (e.g., isolation and severed
 relationship),11,57, behavioral consequences (such as
nondisclosure or concealment),19,35 psychological
 consequences (such as stress, anxiety, depression and
 suicidal ideation),6,58 and medical consequences (such
as delay or disruption of treatment).3,18,20,59 Studies
have indicated that such consequences have an impact
on the overall quality of life of individuals.2,15,59
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Furthermore, they undermine the public health response
and cause a negative impact on their overall effective-
ness.18,19,21
The findings of this study have several implications
for public health research and practice in Indonesia. First,
the prospects of stigma reduction response at different
levels of the society are clear. Studies should focus on
structural and interpersonal levels to minimize enacted
stigma; efforts to changing exclusionary policy, practices,
and social norms and raising awareness and knowledge
to change public perception of the diseases can be
 effective. For felt stigma at an individual level, specific
interventions, such as psychosocial support and peer
counseling, may help. Second, the findings have
 highlighted the importance of understanding and
 respecting the living experiences, experiential knowledge,
and rights of people with health conditions. The findings
warrant a paradigm change from a traditional medical
approach in which affected people are considered
 “patients” or “beneficiaries” to a human rights-based
 approach in which patients are recognized as equals and
key stakeholders with rights and ability to make decisions
on issues that affect their lives at every level of the
 society. Third, considering the similarity in the
 experiences and consequences of stigma under the four
conditions, the strongest approach in effectively
 responding to health-related stigma in the society might
involve the combination of these different stigmatized
health conditions and their shared experiences,
 knowledge, and lessons learned. However, researchers
should study the feasibility and prospects for such an
 integrated and common stigma reduction intervention.
Fourth, while responding to health-related stigma,
 individual differences (e.g., comorbidity, disease severity,
etc.) should be acknowledged. Other social inequalities
and oppressions that shape a person’s experience of
 stigma, such as gender and poverty, should be
 considered. A further study is needed to identify the most
important factor that intersects with health-related
 stigma, and to design interventions that address these
 different inequalities along with health-related stigma, to
effectively reduce stigma. Fifth, the findings indicated an
integral role of the government in forging an alliance with
advocacy groups, civil society, and NGOs to replace
 exclusionary policies and practices and to fight
 superstitious customs and traditions. Further, the
 instances of human rights violations also warrant
 government intervention to ensure all individuals with
diseases protected. Another role of the government can
include leveraging interagency collaboration to tackle
stigma by integrating and uniting response previously
siloed into different diseases and disciplines.
This study also has some limitations. This study only
presents a general outline of stigma experiences and
 consequences, to streamline the scope of research
 findings, but this study does not delve deeper into
 individual differences that may affect the experience and
severity of stigma, such as disease severity, duration of
living with the disease, disability, comorbidity, poverty,
gender, sexuality, and age. Furthermore, this the study
only focuses on the negative experiences of stigma and
exclusion, while positive experiences of coping,
 resilience, and inclusion despite stigma were excluded.  
Conclusion
People living with HIV, leprosy and schizophrenia
still face stigma and its adverse impact on the different
facets of the Indonesian society. Those with diabetes
 either perceive no or less severe stigma. Exclusionary
policies and practices, subjugating social norms,
 superstitious beliefs, and shame, blame and fear from
 societal actors cause the negative experiences of stigma
among affected persons. They experience the social,
 behavioral, psychological, and medical consequences of
stigma. The findings suggest a need for changes in
 policies and practices to prevent exclusion and human
rights violation of stigmatized people and to combine
 advocacy efforts and public health responses to different
diseases in an integrative united front to end stigma. 
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